Cited by 362Fibroblast Growth Factor ResearchDietary Effects on HealthDiet and metabolism studies

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Fibroblast Growth Factor 21-Deficient Mice Demonstrate Impaired Adaptation to Ketosis

Open access

Badman, Michael K., Koester, Anja, Flier, Jeffrey S., Kharitonenkov, Alexei, Maratos-Flier, Eleftheria·2009·Endocrinology

DOI 10.1210/en.2009-0532PMC PMC2775979

Open this paper in CoChat — free account

Abstract

Fibroblast growth factor 21 (FGF21) is a key metabolic regulator. Expressed primarily in liver and adipose tissue, FGF21 is induced via peroxisome proliferator-activated receptor (PPAR) pathways during states requiring increased fatty acid oxidation including fasting and consumption of a ketogenic diet. To test the hypothesis that FGF21 is a physiological regulator that plays a role in lipid oxidation, we generated mice with targeted disruption of the Fgf21 locus (FGF21 knockout). Mice lacking FGF21 had mild weight gain and slightly impaired glucose homeostasis, indicating a role in long-term energy homeostasis. Furthermore, FGF21KO mice tolerated a 24-h fast, indicating that FGF21 is not essential in the early stages of starvation. In contrast to wild-type animals in which feeding KD leads to dramatic weight loss, FGF21KO mice fed KD gained weight, developed hepatosteatosis, and showed marked impairments in ketogenesis and glucose control. This confirms the physiological importance of FGF21 in the adaptation to KD feeding. At a molecular level, these effects were accompanied by lower levels of expression of PGC1alpha and PGC1beta in FGF21KO mice, strongly implicating these key transcriptional regulators in the action of FGF21. Furthermore, within the liver, the maturation of the lipogenic transcription factor sterol regulatory element-binding protein-1c was increased in FGF21KO mice, implicating posttranscriptional events in the maladaptation of FGF21KO mice to KD. These data reinforce the role of FGF21 is a critical regulator of long-term energy balance and metabolism. Mice lacking FGF21 cannot respond appropriately to a ketogenic diet, resulting in an impaired ability to mobilize and utilize lipids.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1210/en.2009-0532

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

FGF-21 as a novel metabolic regulator
Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125
Self-citation
Endocrine Regulation of the Fasting Response by PPARα-Mediated Induction of Fibroblast Growth Factor 21
Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.003 · Cited by 1,504
Hepatic Fibroblast Growth Factor 21 Is Regulated by PPARα and Is a Key Mediator of Hepatic Lipid Metabolism in Ketotic States
Badman, M. K., Pissios, P., Kennedy, A. R., Koukos, G., Flier, J. S., & Maratos-Flier, E. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.002 · Cited by 1,495
Self-citation
Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice
Xu, J., Lloyd, D. J., Hale, C., Stanislaus, S., Chen, M., Sivits, G., Vonderfecht, S., Hecht, R., Li, Y.-S., Lindberg, R. A., et al. (2009) · Diabetes · doi:10.2337/db08-0392 · Cited by 1,151
A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood
Brown, M. S., & Goldstein, J. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11041 · Cited by 1,134
Fibroblast Growth Factor 21 Corrects Obesity in Mice
Coskun, T., Bina, H. A., Schneider, M. A., Dunbar, J. D., Hu, C. C., Chen, Y., Moller, D. E., & Kharitonenkov, A. (2008) · Endocrinology · doi:10.1210/en.2008-0816 · Cited by 1,031
Self-citation
Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans
Zhang, X., Yeung, D. C. Y., Karpisek, M., Stejskal, D., Zhou, Z.-G., Liu, F., Wong, R. L. C., Chow, W.-S., Tso, A. W. K., Lam, K. S. L., et al. (2008) · Diabetes · doi:10.2337/db07-1476 · Cited by 908
Identification of a novel FGF, FGF-21, preferentially expressed in the liver
Nishimura, T., Nakatake, Y., Konishi, M., & Itoh, N. (2000) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(00)00067-1 · Cited by 847
Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a.
Shimano, H., Horton, J. D., Hammer, R. E., Shimomura, I., Brown, M. S., & Goldstein, J. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118951 · Cited by 817
Tissue-specific Expression of βKlotho and Fibroblast Growth Factor (FGF) Receptor Isoforms Determines Metabolic Activity of FGF19 and FGF21
Kurosu, H., Choi, M., Ogawa, Y., Dickson, A. S., Goetz, R., Eliseenkova, A. V., Mohammadi, M., Rosenblatt, K. P., Kliewer, S. A., & Kuro-o, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704165200 · Cited by 748

Show all 27 references

Research works printed but not linked: 1

Koester, 2006, Metabolic evaluation of FGF-21 transgenic mice, Diabetologia, 49, 352

Sorted by citations

Items 201–300 of 361

Metabolic actions of FGF21: molecular mechanisms and therapeutic implications
Ge, X., Wang, Y., Lam, K. S., & Xu, A. (2012) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2012.06.011 · Cited by 35
Regulation of thermogenic adipocytes during fasting and cold
Reinisch, I., Schreiber, R., & Prokesch, A. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.110869 · Cited by 36
Nutritional Ketosis as a Potential Treatment for Alcohol Use Disorder
Mahajan, V. R., Elvig, S. K., Vendruscolo, L. F., Koob, G. F., Darcey, V. L., King, M. T., Kranzler, H. R., Volkow, N. D., & Wiers, C. E. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.781668 · Cited by 34
Plasma from healthy donors protects blood–brain barrier integrity via FGF21 and improves the recovery in a mouse model of cerebral ischaemia
Mamtilahun, M., Jiang, L., Song, Y., Shi, X., Liu, C., Jiang, Y., Deng, L., Zheng, H., Shen, H., Li, Y., et al. (2021) · Stroke and Vascular Neurology · doi:10.1136/svn-2020-000774 · Cited by 33
Fasting-Induced FGF21 Is Repressed by LXR Activation via Recruitment of an HDAC3 Corepressor Complex in Mice
Archer, A., Venteclef, N., Mode, A., Pedrelli, M., Gabbi, C., Clément, K., Parini, P., Gustafsson, J.-Α., & Korach-André, M. (2012) · Molecular Endocrinology · doi:10.1210/me.2012-1151 · Cited by 33
Fibroblast growth factor 21 inhibits atherosclerosis in apoE−/− mice by ameliorating Fas-mediated apoptosis
Yan, X., Gou, Z., Li, Y., Wang, Y., Zhu, J., Xu, G., & Zhang, Q. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0846-x · Cited by 32
A solid-phase PEGylation strategy for protein therapeutics using a potent FGF21 analog
Song, L., Zhu, Y., Wang, H., Belov, A. A., Niu, J., Shi, L., Xie, Y., Ye, C., Li, X., & Huang, Z. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.03.023 · Cited by 32
Cobalt chloride decreases fibroblast growth factor-21 expression dependent on oxidative stress but not hypoxia-inducible factor in Caco-2 cells
Liu, Y., Wang, C., Wang, Y., Ma, Z., Xiao, J., McClain, C. J., Li, X., & Feng, W. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.08.003 · Cited by 32
Recent advances in understanding the role of adipocytokines during non-alcoholic fatty liver disease pathogenesis and their link with hepatokines
Panera, N., Corte, C. D., Crudele, A., Stronati, L., Nobili, V., & Alisi, A. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2016.1110485 · Cited by 31
The Ablation of Mitochondrial Protein Phosphatase Pgam5 Confers Resistance Against Metabolic Stress
Sekine, S., Akari, Y., Hattori, K., Sugawara, S., Naguro, I., Koike, M., Uchiyama, Y., Takeda, K., & Ichijo, H. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.01.031 · Cited by 31
Anti-inflammatory effects of exercise training in adipose tissue do not require FGF21
Porter, J. W., Rowles, J. L., Fletcher, J. A., Zidon, T. M., Winn, N. C., McCabe, L., Park, Y.-M., Perfield, J. W., Thyfault, J. P., Rector, R. S., et al. (2017) · Journal of Endocrinology · doi:10.1530/joe-17-0190 · Cited by 31
Fibroblast growth Factor-21 promotes ketone body utilization in neurons through activation of AMP-dependent kinase
Katsu-Jiménez, Y., & Giménez-Cassina, A. (2019) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2019.103415 · Cited by 34
Circulating FGF19 and FGF21 surge in early infancy from infra- to supra-adult concentrations
Sánchez‐Infantes, D., Gallego-Escuredo, J. M., Díaz, M., Aragonès, G., Sebastiani, G., López‐Bermejo, A., de Zegher, F., Domingo, P., Villarroya, F., & Ibáñez, L. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.2 · Cited by 30
FGF21 as a Therapeutic Reagent
Zhao, Y., Dunbar, J. D., & Kharitonenkov, A. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0887-1_14 · Cited by 30
Self-citation
Prolonged Glucagon Infusion Does Not Affect Energy Expenditure in Individuals with Overweight/Obesity: A Randomized Trial
Whytock, K. L., Carnero, E. A., Vega, R. B., Tillner, J., Bock, C., Chivukula, K., Yi, F., Meyer, C., Smith, S. R., & Sparks, L. M. (2021) · Obesity · doi:10.1002/oby.23141 · Cited by 30
Effects of Short-Term Continuous Subcutaneous Insulin Infusion on Fasting Plasma Fibroblast Growth Factor-21 Levels in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
Yang, M., Dong, J., Liu, H., Li, L., & Yang, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026359 · Cited by 30
Evaluation of concentrations of FGF-21 - a new adipocytokine in type 2 diabetes.
Matuszek, B., Lenart-Lipińska, M., Duma, D., Solski, J., & Nowakowski, A. M. (2010) · PubMed · Cited by 30
Sex differences and aging: Is there a role of brown adipose tissue?
Hoffman, J. M., & Valencak, T. G. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111310 · Cited by 29
Pancreatic Islet Responses to Metabolic Trauma
Burke, S. J., Karlstad, M. D., & Collier, J. J. (2016) · Shock · doi:10.1097/shk.0000000000000607 · Cited by 28
Hepatic AKT orchestrates adipose tissue thermogenesis via FGF21-dependent and -independent mechanisms
Sostre‐Colón, J., Uehara, K., Whitlock, A. E. G., Gavin, M. J., Ishibashi, J., Potthoff, M. J., Seale, P., & Titchenell, P. M. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109128 · Cited by 26
Effect of circulating glucagon and free fatty acids on hepatic FGF21 production in dairy cows
Caixeta, L. S., Giesy, S. L., Krumm, C. S., Perfield, J. W., Butterfield, A. M., Schoenberg, K. M., Beitz, D. C., & Boisclair, Y. R. (2017) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00197.2017 · Cited by 29
Fibroblast Growth Factor Binding Protein 3 (FGFBP3) impacts carbohydrate and lipid metabolism
Tassi, E., Garman, K. A., Schmidt, M. O., Ma, X., Kabbara, K. W., Üren, A., Tomita, Y. A., Goetz, R. M., Mohammadi, M., Wilcox, C. S., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-34238-5 · Cited by 28
FGF21 Mimics a Fasting-Induced Metabolic State and Increases Appetite in Zebrafish
Blanco, A. M., Bertucci, J. I., & Unniappan, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-63726-w · Cited by 26
FGF21 protects against ox-LDL induced apoptosis through suppressing CHOP expression in THP1 macrophage derived foam cells
Li, E., Wang, T., Wang, F., Wang, T., Sun, L., Li, L., Niu, S., & Zhang, J. (2015) · BMC Cardiovascular Disorders · doi:10.1186/s12872-015-0077-2 · Cited by 26
FGF21 regulates insulin sensitivity following long-term chronic stress
Jeleník, T., Dille, M. A., Müller-Lühlhoff, S., Kabra, D. G., Zhou, Z., Binsch, C., Hartwig, S., Lehr, S., Chadt, A., Peters, E. M. J., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.06.012 · Cited by 26
β-Klotho deficiency shifts the gut-liver bile acid axis and induces hepatic alterations in mice
Somm, E., Henry, H., Bruce, S. J., Bonnet, N., Montandon, S. A., Niederländer, N. J., Messina, A., Aeby, S., Rosikiewicz, M., Fajas, L., et al. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00182.2018 · Cited by 28
Effect of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) on Hormones of Energy Balance in a TCDD-Sensitive and a TCDD-Resistant Rat Strain
Lindén, J., Lensu, S., & Pohjanvirta, R. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150813938 · Cited by 25
The cell adhesion molecule L1 regulates the expression of FGF21 and enhances neurite outgrowth
Huang, X., Hu, J., Li, Y., Yang, Z. Z., Zhu, H., Zhou, L., Ma, K., Schachner, M., Xiao, Z., & Li, Y. (2013) · Brain Research · doi:10.1016/j.brainres.2013.07.043 · Cited by 24
FoxO1 suppresses Fgf21 during hepatic insulin resistance to impair peripheral glucose utilization and acute cold tolerance
Stöhr, O., Tao, R., Miao, J., Copps, K. D., & White, M. F. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108893 · Cited by 24
Endocrine Fibroblast Growth Factors in Relation to Stress Signaling
Shimizu, M., & Sato, R. (2022) · Cells · doi:10.3390/cells11030505 · Cited by 25
Role of liver FGF21-KLB signaling in ketogenic diet-induced amelioration of hepatic steatosis
Guo, W., Cao, H., Shen, Y., Li, W., Wang, W. J., Cheng, L., Cai, M., & Xu, F. L. (2024) · Nutrition and Diabetes · doi:10.1038/s41387-024-00277-3 · Cited by 24
Fibroblast Growth Factor 21 (Fgf21) Gene Expression Is Elevated in the Liver of Mice Fed a High-Carbohydrate Liquid Diet and Attenuated by a Lipid Emulsion but Is Not Upregulated in the Liver of Mice Fed a High-Fat Obesogenic Diet
Hao, L., Huang, N. K., Ito, K., Sae‐tan, S., Lambert, J. D., & Ross, A. C. (2016) · Journal of Nutrition · doi:10.3945/jn.115.216572 · Cited by 24
Alterations in Hepatic FGF21, Co-Regulated Genes, and Upstream Metabolic Genes in Response to Nutrition, Ketosis and Inflammation in Peripartal Holstein Cows
Akbar, H., Batistel, F., Drackley, J. K., & Loor, J. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139963 · Cited by 23
Polymerase gamma mutator mice rely on increased glycolytic flux for energy production
Saleem, A., Safdar, A., Kitaoka, Y., Ma, X., Marquez, O., Akhtar, M., Nazli, A., Suri, R., Turnbull, J. D., & Tarnopolsky, M. A. (2015) · Mitochondrion · doi:10.1016/j.mito.2014.12.001 · Cited by 23
Novel Molecules Regulating Energy Homeostasis: Physiology and Regulation by Macronutrient Intake and Weight Loss
Gavrieli, A., & Mantzoros, C. S. (2016) · Endocrinology and Metabolism · doi:10.3803/enm.2016.31.3.361 · Cited by 21
Role of GPRC6A in Regulating Hepatic Energy Metabolism
Pi, M., Xu, F., Ye, R.-S., Nishimoto, S. K., Williams, R. W., Williams, R. W., Lu, L., & Quarles, L. D. (2019) · Scientific Reports · doi:10.1038/s41598-020-64384-8 · Cited by 22
Short-Term Ketogenic Diet Induces a Molecular Response That Is Distinct From Dietary Protein Restriction
Kalafut, K. C., Mitchell, S. J., MacArthur, M. R., & Mitchell, J. R. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.839341 · Cited by 22
Hepatic FGF21 production is increased in late pregnancy in the mouse
Cui, Y., Giesy, S. L., Hassan, M., Davis, K., Zhao, S., & Boisclair, Y. R. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00554.2013 · Cited by 21
Cholic Acid Supplementation of a High-Fat Obesogenic Diet Suppresses Hepatic Triacylglycerol Accumulation in Mice via a Fibroblast Growth Factor 21–Dependent Mechanism
Ippagunta, S. M., Kharitonenkov, A., Adams, A. C., & Hillgartner, F. B. (2018) · Journal of Nutrition · doi:10.1093/jn/nxy022 · Cited by 21
Self-citation
Fibroblast growth factor-21 (FGF21) administration to early-lactating dairy cows. II. Pharmacokinetics, whole-animal performance, and lipid metabolism
Caixeta, L. S., Giesy, S. L., Krumm, C. S., Perfield, J. W., Butterfield, A. M., & Boisclair, Y. R. (2019) · Journal of Dairy Science · doi:10.3168/jds.2019-16696 · Cited by 20
Fibroblast growth factor 21: A new liver safeguard
Cariello, M., & Moschetta, A. (2014) · Hepatology · doi:10.1002/hep.27147 · Cited by 20
Obesity and Exercise: New Insights and Perspectives
James, N. M., & Stanford, K. I. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf017 · Cited by 20
The Potential Roles of Myokines in Adipose Tissue Metabolism with Exercise and Cold Exposure
Jiang, S., Bae, J. H., Wang, Y., & Song, W. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911523 · Cited by 20
A novel fatty acid mimetic with pan-PPAR partial agonist activity inhibits diet-induced obesity and metabolic dysfunction-associated steatotic liver disease
Sahin, C., Melanson, J.-R., Billan, F. L., Magomedova, L., Ferreira, T. A. M., de Oliveira, A. S., Pollock‐Tahiri, E., Saikali, M. F., Cash, S. B., Woo, M., et al. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.101958 · Cited by 19
Transcriptional control and hormonal response of thermogenic fat
Emont, M. P., Yu, H. M., & Wu, J. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0026 · Cited by 19
Cardiac myocyte KLF5 regulates body weight via alteration of cardiac FGF21
Pol, C. J., Pollak, N. M., Jurczak, M. J., Zacharia, E. M., Karagiannides, I., Kyriazis, I. D., Ntziachristos, P., Scerbo, D. A., Brown, B. R., Aifantis, I., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.04.010 · Cited by 18
Increased fructose consumption has sex‐specific effects on fibroblast growth factor 21 levels in humans
Rodgers, M., Heineman, B. D., & Dushay, J. R. (2019) · Obesity Science & Practice · doi:10.1002/osp4.360 · Cited by 17
Fibroblast Growth Factor 21 Is Not Required for the Reductions in Circulating Insulin-Like Growth Factor-1 or Global Cell Proliferation Rates in Response to Moderate Calorie Restriction in Adult Mice
Thompson, A. C. S., Bruss, M. D., Nag, N., Kharitonenkov, A., Adams, A. C., & Hellerstein, M. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111418 · Cited by 17
Self-citation
Fibroblast Growth Factor 21-Null Mice Do Not Exhibit an Impaired Response to Fasting
Antonellis, P. J., Hayes, M. P., & Adams, A. C. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00077 · Cited by 17
Physiology and Endocrinology Symposium: FGF21: Insights into mechanism of action from preclinical studies1,2
Antonellis, P. J., Kharitonenkov, A., & Adams, A. C. (2014) · Journal of Animal Science · doi:10.2527/jas.2013-7076 · Cited by 15
Self-citation
Humanized GPRC6AKGKY is a gain-of-function polymorphism in mice
Pi, M., Xu, F., Ye, R.-S., Nishimoto, S. K., Kesterson, R. A., Williams, R. W., Lu, L., & Quarles, L. D. (2020) · Scientific Reports · doi:10.1038/s41598-020-68113-z · Cited by 16
Reduction of Plasma BCAAs following Roux-en-Y Gastric Bypass Surgery Is Primarily Mediated by FGF21
Shah, H., Kramer, A., Mullins, C. A., Mattern, M., Gannaban, R. B., Townsend, R. L., Campagna, S. R., Morrison, C. D., Berthoud, H., & Shin, A. C. (2023) · Nutrients · doi:10.3390/nu15071713 · Cited by 17
Effect of Fibroblast Growth Factor 21 on the Development of Atheromatous Plaque and Lipid Metabolic Profiles in an Atherosclerosis-Prone Mouse Model
Maeng, H. J., Lee, G. Y., Bae, J. H., & Lim, S. K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186836 · Cited by 16
Transplantation of committed pre-adipocytes from brown adipose tissue improves whole-body glucose homeostasis
Dewal, R. S., Yang, F. T., Baer, L. A., Vidal, P., Hernández‐Saavedra, D., Seculov, N. P., Ghosh, A., Noé, F., Togliatti, O., Hughes, L., et al. (2024) · iScience · doi:10.1016/j.isci.2024.108927 · Cited by 16
Fibroblast growth factor 21
Trusz, G. J. (2024) · Differentiation · doi:10.1016/j.diff.2024.100793 · Cited by 15
The Effects of Rumen-Protected Choline and Rumen-Protected Nicotinamide on Liver Transcriptomics in Periparturient Dairy Cows
Du, X., Cui, Z., Zhang, R., Zhao, K., Wang, L., Yao, J., Liu, S., Cai, C., & Cao, Y. (2023) · Metabolites · doi:10.3390/metabo13050594 · Cited by 16
Hepatic, adipocyte, enteric and pancreatic hormones: response to dietary macronutrient composition and relationship with metabolism
Hron, B. M., Ebbeling, C. B., Feldman, H. A., & Ludwig, D. S. (2017) · Nutrition & Metabolism · doi:10.1186/s12986-017-0198-y · Cited by 15
Oroxylin-A alleviates hepatic lipid accumulation and apoptosis under hyperlipidemic conditions via AMPK/FGF21 signaling
Cho, W., Choi, S. W., Oh, H., El‐Aty, A. M. A., Hacımüftüoğlu, A., Jeong, J. H., Song, J.-H., Shin, Y. K., & Jung, T. W. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.01.090 · Cited by 14
Short‐term semaglutide treatment improves FGF21 responsiveness in primary hepatocytes isolated from high fat diet challenged mice
Feng, J. N., Shao, W., & Jin, T. (2023) · Physiological Reports · doi:10.14814/phy2.15620 · Cited by 13
Hepatic function of glucagon-like peptide-1 and its based diabetes drugs
Feng, J. N., & Jin, T. (2024) · Medical Review · doi:10.1515/mr-2024-0018 · Cited by 17
The effects of exercise on FGF21 in adults: a systematic review and meta-analysis
Liu, C., Yan, X., Zong, Y., He, Y., Yang, G., Xiao, Y., & Wang, S. (2024) · PeerJ · doi:10.7717/peerj.17615 · Cited by 14
Oleuropein mitigates non‐alcoholic fatty liver disease (NAFLD) and modulates liver metabolites in high‐fat diet‐induced obese mice via activating PPARα
Zhou, W., & Du, Z. (2024) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.13691 · Cited by 14
FGF21 Signaling Exerts Antifibrotic Properties during Pulmonary Fibrosis
Ghanem, M., Archer, G., Justet, A., Jaillet, M., Vasarmidi, E., Mordant, P., Castier, Y., Mal, H., Cazes, A., Poté, N., et al. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202311-2021oc · Cited by 16
Ketone body and FGF21 coordinately regulate fasting-induced oxidative stress response in the heart
Kawakami, R., Sunaga, H., Iso, T., Kaneko, R., Koitabashi, N., Obokata, M., Harada, T., Matsui, H., Yokoyama, T., & Kurabayashi, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-10993-4 · Cited by 14
Liver‐derived FGF21 is required for the effect of time‐restricted feeding on high‐fat diet‐induced fatty liver in mice
Hua, L., Li, J., Yang, Y., Jiang, D., Jiang, X., Han, X., Jin, C., Feng, B., Che, L., Xu, S., et al. (2023) · The FASEB Journal · doi:10.1096/fj.202202031r · Cited by 14
Pubertal FGF21 deficit is central in the metabolic pathophysiology of an ovine model of polycystic ovary syndrome
Siemienowicz, K. J., Furmanska, K., Filis, P., Talia, C., Thomas, J. L., Fowler, P., Rae, M. T., & Duncan, W. C. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111196 · Cited by 13
Effect of vanillic acid and exercise training on fatty liver and insulin resistance in rats: Possible role of fibroblast growth factor 21 and autophagy
Obydah, W., Shaker, G. A., Samir, S. M., El-Basiony, S. F., & Abd-Elmoniem, H. A. (2021) · Physiology International · doi:10.1556/2060.2021.00188 · Cited by 13
Fibroblast growth factor 21 and fructose dynamics in humans
Migdal, A. L., Comte, S., Rodgers, M., Heineman, B. D., Maratos–Flier, E., Herman, M. A., & Dushay, J. R. (2018) · Obesity Science & Practice · doi:10.1002/osp4.295 · Cited by 12
Self-citation
MS-275 induces hepatic FGF21 expression via H3K18ac-mediated CREBH signal
Zhang, Q., Zhu, Q., Deng, R., Zhou, F., Zhang, L., Wang, S., Zhu, K., Wang, X. R., Zhou, L., & Su, Q. (2019) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0259 · Cited by 13
Low-Carbohydrate Ketogenic Diet for Improvement of Glycemic Control: Mechanism of Action of Ketosis and Beneficial Effects
Das, S., Sakr, H. F., Sirasanagandla, S. R., Bima, A. I. H., & Elsamanoudy, A. Z. (2022) · Current Diabetes Reviews · doi:10.2174/1573399818666220511121629 · Cited by 13
White adipose tissue in type 2 diabetes and the effect of antidiabetic drugs
Zhao, Y., & Yue, R. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01678-9 · Cited by 13
X-linked hypophosphatemia, obesity and arterial hypertension: data from the XLH21 study
Bloudeau, L., Linglart, A., Flammier, S., Portefaix, A., Bertholet‐Thomas, A., Eddiry, S., Barosi, A., Salles, J., Porquet‐Bordes, V., Rothenbühler, A., et al. (2022) · Pediatric Nephrology · doi:10.1007/s00467-022-05636-9 · Cited by 12
Prognostic value of plasma fibroblast growth factor 21 among patients with acute ischemic stroke
Zheng, X., Zhu, Z., Guo, D., Zhong, C., Xu, T., Peng, Y., Wang, A., Peng, H. Y., Ju, Z., Geng, D., et al. (2020) · European Journal of Neurology · doi:10.1111/ene.14683 · Cited by 12
Impact of Fibroblast Growth Factors 19 and 21 in Bariatric Metabolism
Patton, A., Khan, F. H., & Kohli, R. (2017) · Digestive Diseases · doi:10.1159/000450910 · Cited by 13
Nutrient-Dependent Acetylation Controls Basic Regulatory Metabolic Switches and Cellular ReprogrammingPreprint
Dominy, J. E., Gerhart‐Hines, Z., & Puigserver, P. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2012.76.010843 · Cited by 12
Hepato-cardiac interorgan communication controls cardiac hypertrophy via combined endocrine-autocrine FGF21 signaling
Mia, S., Siokatas, G., Sidiropoulou, R., Hoffman, M., Fragkiadakis, K., Markopoulou, E., Elesawy, M., Roy, R., Blair, S., Kuwabara, Y., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102125 · Cited by 11
The endocrine FGFs axis: A systemic anti-fibrotic response that could prevent pulmonary fibrogenesis?
Ghanem, M., Archer, G., Crestani, B., & Mailleux, A. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108669 · Cited by 12
Reduced adiposity attenuates FGF21 mediated metabolic improvements in the Siberian hamster
Lewis, J. E., Samms, R. J., Cooper, S., Luckett, J., Perkins, A. C., Adams, A. C., Tsintzas, K., & Ebling, F. J. P. (2017) · Scientific Reports · doi:10.1038/s41598-017-03607-x · Cited by 11
Pharmacologic stimulation of central GLP-1 receptors has opposite effects on the alterations of plasma FGF21 levels induced by feeding and fasting
Nonogaki, K., Kaji, T., Yamazaki, T., & Murakami, M. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.12.011 · Cited by 11
Changes in hepatic triglyceride content with the activation of ER stress and increased FGF21 secretion during pregnancy
Lu, J., Gong, Y., Wei, X., Yao, Z., Yang, R., Xin, J., Gao, L., & Shao, S. (2021) · Nutrition & Metabolism · doi:10.1186/s12986-021-00570-3 · Cited by 12
Investigation of Metabolic and Inflammatory Disorder in the Aging FGF21 Knockout Mouse
Cai, L., Li, X., Wang, Y., Chen, Y., Zhu, X., Zuo, Z., Si-Ma, Y.-Q., Lin, Y., Li, X., & Huang, X. (2024) · Inflammation · doi:10.1007/s10753-024-02032-3 · Cited by 10
Practical prospects for boosting hepatic production of the “pro-longevity” hormone FGF21
McCarty, M. F. (2015) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2015-0057 · Cited by 10
Identification of IQ motif–containing GTPase-activating protein 1 as a regulator of long-term ketosis
Erickson, H. L., & Anakk, S. (2018) · JCI Insight · doi:10.1172/jci.insight.99866 · Cited by 9
Physiological concentrations of β-hydroxybutyrate do not promote adipocyte browning
Caminhotto, R. D. O., Andreotti, S., Komino, A. C. M., Silva, F. D. F., Sertié, R. A. L., Christoffolete, M. A., Reis, G. B., & Lima, F. B. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116683 · Cited by 10
The relationship between serum adipokine fibroblast growth factor‐21 and gestational diabetes mellitus
Jia, X., Bai, L., Ma, N., & Lu, Q. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13889 · Cited by 10
Ketogenic Diet Combined with Moderate Aerobic Exercise Training Ameliorates White Adipose Tissue Mass, Serum Biomarkers, and Hepatic Lipid Metabolism in High-Fat Diet-Induced Obese Mice
Yan, J., Ren, C., Dong, Y., Wali, J. A., Song, H., Zhang, Y., Zhang, H., Kou, G., Raubenheimer, D., & Cui, Z. (2023) · Nutrients · doi:10.3390/nu15010251 · Cited by 12
Chronic Prednisolone Treatment Aggravates Hyperglycemia in Mice Fed a High-Fat Diet but Does Not Worsen Dietary Fat-Induced Insulin Resistance
Laskewitz, A. J., van Dijk, T. H., Grefhorst, A., van Lierop, M.-J., Schreurs, M., Bloks, V. W., Reijngoud, D., Dokter, W. H. A., Kuipers, F., & Groen, A. K. (2012) · Endocrinology · doi:10.1210/en.2011-1891 · Cited by 10
Mitiglinide treatment may decreases plasma fibroblast growth factor-21 levels in individuals with new-onset T2DM
Wang, B., Yang, G., Yang, M., Liao, Y., Li, Z., Boden, G. H., & Li, L. (2011) · Cytokine · doi:10.1016/j.cyto.2011.11.002 · Cited by 10
Research progress on the role of FGF21 in insulin resistance
Zhang, H., Zhu, R., Sun, Q., & Du, L. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1619462 · Cited by 10
Adipose angiotensin II type 1 receptor-associated protein ameliorates metabolic disorders via promoting adipose tissue adipogenesis and browning
Luo, C., Lv, N., Chang, Z., Qu, Q., & Huang, J. (2017) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2017.05.003 · Cited by 9
Fibroblast growth factor 21 induces lipolysis more efficiently than it suppresses lipogenesis in goat adipocytes
Zhang, Y., Li, L., Wang, Q., Zhan, S., Wang, L., Zhong, T., Guo, J., & Zhang, H. (2018) · Cytotechnology · doi:10.1007/s10616-018-0237-1 · Cited by 10
Optimization of Peptide Inhibitors of β-Klotho as Antagonists of Fibroblast Growth Factors 19 and 21
Pan, J. B., Parlee, S. D., Brunel, F. M., Li, P., Lu, W., Pérez–Tilve, D., Liu, F., Finan, B., Kharitonenkov, A., & DiMarchi, R. D. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00100 · Cited by 9
Self-citation
More than meets the islet: aligning nutrient and paracrine inputs with hormone secretion in health and disease
Morriseau, T. S., Doucette, C. A., & Dolinsky, V. W. (2022) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00411.2021 · Cited by 9
Fibroblast growth factor 21 – a key player in cardiovascular disorders?
Lenart-Lipińska, M., Duma, D., Hałabiś, M., Dziedzic, M., & Solski, J. (2016) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2016-0026 · Cited by 8
Commentary: FGF21 Holds Promises for Treating Obesity-related Insulin Resistance and Hepatosteatosis
Alisi, A., Panera, N., & Nobili, V. (2013) · Endocrinology · doi:10.1210/en.2013-1828 · Cited by 8
Roles of FGF21 and irisin in obesity-related diabetes and pancreatic diseases
Xie, T., & Leung, P. S. (2020) · Journal of Pancreatology · doi:10.1097/jp9.0000000000000039 · Cited by 7
Metabogenomic analysis to functionally annotate the regulatory role of long non-coding RNAs in the liver of cows with different nutrient partitioning phenotype
Nolte, W., Weikard, R., Albrecht, E., Hammon, H. M., & Kühn, C. (2021) · Genomics · doi:10.1016/j.ygeno.2021.12.004 · Cited by 7
MAPL loss dysregulates bile and liver metabolism in mice
Goyon, V., Besse‐Patin, A., Zunino, R., Ignatenko, O., Nguyen, M., Coyaud, É., Lee, J. M., Nguyen, B., Raught, B., & McBride, H. M. (2023) · EMBO Reports · doi:10.15252/embr.202357972 · Cited by 6
NS5ATP6 modulates intracellular triglyceride content through FGF21 and independently of SIRT1 and SREBP1
Li, Z., Feng, S., Zhou, L., Liu, S., & Cheng, J. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.05.056 · Cited by 6
Normal FGF-21-Serum Levels in Patients with Carnitine Palmitoyltransferase II (CPT II) Deficiency
Scholle, L. M., Lehmann, D., Joshi, P. R., & Zierz, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061400 · Cited by 6

Authors: Badman, M. K., Koester, A., Flier, J. S., Kharitonenkov, A., & Maratos-Flier, E.
Affiliations: Beth Israel Deaconess Medical Center (US)
BioTechnology Discovery Research (A.Ko., A.Kh.), Lilly Research Laboratories, Indianapolis, Indiana 46285
Eli Lilly (United States) (US)
Division of Endocrinology, Diabetes, and Metabolism (M.K.B., J.S.F., E.M.-F.), Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215;
ORCID: Flier, Jeffrey S.
Kharitonenkov, Alexei
Venue: Endocrinology
Publisher: The Endocrine Society
Published: 2009-10-09
Volume: 150
Issue: 11
Pages: 4931-4940
ISSN: 0013-7227 (ISSN-L)
1945-7170
DOI: 10.1210/en.2009-0532
PMC: PMC2775979
OpenAlex: W2020958481
Cited by: 362
References: 27
Citations by year: 2026: 8 · 2025: 12 · 2024: 19 · 2023: 15 · 2022: 13 · 2021: 24 · 2020: 24 · 2019: 25 · 2018: 22 · 2017: 26 · 2016: 27 · 2015: 30 · 2014: 20 · 2013: 25 · 2012: 36
FWCI: 9.72
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Endocrinology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Eli Lilly and Company
National Institutes of Health (5r01dk069983-05)
National Institute of Diabetes and Digestive and Kidney Diseases (P01DK056116, P30DK046200, R01-DK-069983, R37DK028082)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
Keywords: FGF21, FGF21 knockout mice, ketogenic diet, ketogenesis, fasting tolerance, energy homeostasis, PGC-1α, PGC-1β, SREBP-1c, hepatic steatosis, lipid oxidation, glucose homeostasis, weight gain
MeSH terms: Animals, Disease Models, Animal, Energy Metabolism, Fatty Liver, Female, Fibroblast Growth Factors, Glucose, Humans, Ketosis, Male, Mice, Inbred C57BL, Mice, Knockout, Gene Silencing, Lipid Metabolism, Mice, Diet, Ketogenic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Fibroblast Growth Factor 21-Deficient Mice Demonstrate Impaired Adaptation to Ketosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks